These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16167970)
21. Review article: the long-term use of proton-pump inhibitors. Raghunath AS; O'Morain C; McLoughlin RC Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660 [TBL] [Abstract][Full Text] [Related]
22. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine. Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089 [TBL] [Abstract][Full Text] [Related]
23. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gillen D; Wirz AA; Ardill JE; McColl KE Gastroenterology; 1999 Feb; 116(2):239-47. PubMed ID: 9922302 [TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952 [TBL] [Abstract][Full Text] [Related]
25. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment. Miner PB; Allgood LD; Grender JM Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225 [TBL] [Abstract][Full Text] [Related]
26. Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Maróstica M; Arçari DP; Bartchewsky W; Trevisan M; Ribeiro ML; Pedrazzoli J; Hoehr NF; Gambero A Scand J Gastroenterol; 2007 Dec; 42(12):1404-12. PubMed ID: 17994467 [TBL] [Abstract][Full Text] [Related]
27. Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole. Ortiz RA; Calafatti SA; Corazzi A; Souza JM; Deguer M; De Souza CA; Marchioretto MA; Bernasconi G; Ferraz JG; Pedrazzoli J Aliment Pharmacol Ther; 2002 Jun; 16(6):1163-70. PubMed ID: 12030960 [TBL] [Abstract][Full Text] [Related]
28. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104 [TBL] [Abstract][Full Text] [Related]
29. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection. Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284 [TBL] [Abstract][Full Text] [Related]
30. Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy. Mowat C; McColl KE Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):523-37. PubMed ID: 11403544 [TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Woodward M; Tunstall-Pedoe H; McColl K Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):233-7. PubMed ID: 11293441 [TBL] [Abstract][Full Text] [Related]
33. Influence of Helicobacter pylori infection and omeprazole treatment on gastric regional CO2. Leodolter A; Glasbrenner B; Wiedeck H; Eberhardt H; Malfertheiner P; Brinkmann A Digestion; 2003; 67(4):179-85. PubMed ID: 12966225 [TBL] [Abstract][Full Text] [Related]
34. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent? Smout AJ Scand J Gastroenterol Suppl; 1998; 225():32-5. PubMed ID: 9515750 [TBL] [Abstract][Full Text] [Related]
35. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Evrengul H; Tanriverdi H; Kuru O; Enli Y; Yuksel D; Kilic A; Kaftan A; Kirac S; Kilic M Helicobacter; 2007 Aug; 12(4):298-305. PubMed ID: 17669101 [TBL] [Abstract][Full Text] [Related]
36. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092 [TBL] [Abstract][Full Text] [Related]
37. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Verdú EF; Armstrong D; Idström JP; Labenz J; Stolte M; Dorta G; Börsch G; Blum AL Gut; 1995 Dec; 37(6):743-8. PubMed ID: 8537042 [TBL] [Abstract][Full Text] [Related]
38. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach. Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908 [TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood. Wex T; Kuester D; Vieth M; Treiber G; Krieg A; Roessner A; Malfertheiner P Scand J Gastroenterol; 2008; 43(10):1194-201. PubMed ID: 18609127 [TBL] [Abstract][Full Text] [Related]
40. Can famotidine and omeprazole be combined on a once-daily basis? Fändriks L; Lönroth H; Pettersson A; Vakil N Scand J Gastroenterol; 2007 Jun; 42(6):689-94. PubMed ID: 17505990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]